Tabula Rasa HealthCare saw no growth in patent filings and highest growth of 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Tabula Rasa HealthCare‘s patent filings and grants. Buy the databook here.
Tabula Rasa HealthCare has been focused on protecting inventions in European Patent Office(EPO) with one publication in Q2 2024
The European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where Tabula Rasa HealthCare is filings its patents. Among the top granted patent authorities, Tabula Rasa HealthCare has 100% of its grants in United States(US).
International Business Machines could be the strongest competitor for Tabula Rasa HealthCare
Patents related to electronic medical record (emr) systems and healthtech lead Tabula Rasa HealthCare's portfolio
Tabula Rasa HealthCare has the highest number of patents in electronic medical record (emr) systems followed by, healthtech and remote patient monitoring.
Electronic document mgmt related patents lead Tabula Rasa HealthCare portfolio
Tabula Rasa HealthCare has highest number of patents in electronic document mgmt.
For comprehensive analysis of Tabula Rasa HealthCare's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.